Clinical Trials Browser

Terminated × INDUSTRY × iberdomide × Clear all

NCT04464798 2025-04-29

A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas

Phase 1 Terminated

Lymphoma, Recurrence

NCT05289492 2024-10-26

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

Phase 1 Terminated

Multiple Myeloma